March 27, 2017

Integrated Pest Management Pilot Project implemented in Punjab & Haryana

ICAR & Bayer partner cotton farmers for effective whitefly management

Cotton farmers in Punjab & Haryana have grappled with whitefly attack since last two years/ Integrated Pest Management Project implemented under guidance from ICAR-CICR, NCIPM, KVK, Department of Agriculture officials and State Agricultural Universities/ 5 villages selected in Punjab & Haryana, each for pilot phase of the project/ Project farmers achieved a good average yield of over 1000 kg of seed cotton / acre

Chandigarh, March 27, 2017: Since 2015, whitefly has created havoc in cotton farms, significantly reducing yields and causing heavy losses to cotton farmers in Punjab and Haryana: two key cotton growing states in India. Bayer India’s Crop Science division undertook an Integrated Pest Management (IPM) Project in Punjab and Haryana, to help cotton farmers effectively manage the dreaded whitefly menace.

The idea of implementing a window-based Integrated Pest Management Project to manage whitefly in Punjab and Haryana was proposed at the “Whitefly Management Symposium” organised by Crop Life India and ICAR on March 2, 2016 in New Delhi. Post the meeting; Bayer implemented a joint initiative for effective whitefly management under guidance from the Central Institute of Cotton Research (CICR) at Sirsa, Haryana; the Krishi Vigyan Kendra (KVK) at Fatehabad, Haryana and officials from the Department of Agriculture, Punjab,

The initiative was implemented as a pilot during the 2016 cotton growing season in 5 villages in Bhatinda district of Punjab (Baghu, Mehta, Kotshamir, Jodhpur Romana & Jassi Pavwali) and 5 villages in Fatehabad district of Haryana, (Nehla, Baijalpur, Gorakhpur, Jandli Khurd and Leheriya).

Appreciating the joint initiative, Dr. Jeet Singh Sandhu, Deputy Director General (Crop Science), ICAR said: “The collaborative efforts by the Central Institute of Cotton Research (CICR), the State Agricultural University, State Department of Agriculture and Bayer have yielded desired results and helped project cotton farmers manage the whitefly menace in a timely manner.”

Nearly 100 project cotton growers in both states were guided on the selection of cotton hybrids, sowing time, precautions while buying, transporting, storing and using crop protection chemicals, application of balance fertilizers and irrigation requirements as recommended by officals of the State Agriculture Department. Besides this, cotton growers were also guided on scouting techniques and on methods of taking informed pest management decisions for whitefly-based on economic threshold level of the pest throughout the season.

Summing up the results of the joint initiative, Peter Mueller, Head of Crop Science in South Asia, said: “In both Punjab and Haryana, whitefly was effectively managed and project cotton farmers achieved a good average yield of seed cotton of over 1000 kg of seed cotton / acre. This is a remarkable yield improvement from the previous two years when cotton farmers obtained very low yields due to severe attack of whitefly.”

Cotton growers and government officials have appreciated the efforts of ICAR and Bayer to address the whitefly menace during the 2016 cotton season. They have also expressed their desire for the project to be extended beyond 2016, to cover other affected areas within the cotton producing belt. In addition, key government officials from the Department of Agriculture have reiterated their commitment to further support farmers in areas of soil and irrigation water testing post harvesting of wheat, which will help farmers take informed decisions on fertilizer management. The Integrated Pest Management project will continue in the same 5 villages of Punjab and Haryana till the end of 2018.

Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2016, the Group employed around 115,200 people and had sales of EUR 46.8 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.7 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to

Media Contact:
Saswati Panigrahi
Communications, Bayer Group in India
Tel. +91-22-2531-1097

Cautionary Statements Regarding Forward-Looking Information
Certain statements contained in this communication may constitute “forward-looking statements.” Actual results could differ materially from those projected or forecast in the forward-looking statements. The factors that could cause actual results to differ materially include the following: the risk that Monsanto Company’s (“Monsanto”) stockholders do not approve the transaction; uncertainties as to the timing of the transaction; the possibility that the parties may be unable to achieve expected synergies and operating efficiencies in the merger within the expected time-frames or at all and to successfully integrate Monsanto’s operations into those of Bayer Aktiengesellschaft (“Bayer”); such integration may be more difficult, time-consuming or costly than expected; revenues following the transaction may be lower than expected; operating costs, customer loss and business disruption (including, without limitation, difficulties in maintaining relationships with employees, customers, clients or suppliers) may be greater than expected following the transaction; the retention of certain key employees at Monsanto; risks associated with the disruption of management’s attention from ongoing business operations due to the transaction; the conditions to the completion of the transaction may not be satisfied, or the regulatory approvals required for the transaction may not be obtained on the terms expected or on the anticipated schedule; the parties’ ability to meet expectations regarding the timing, completion and accounting and tax treatments of the merger; the impact of indebtedness incurred by Bayer in connection with the transaction and the potential impact on the rating of indebtedness of Bayer; the effects of the business combination of Bayer and Monsanto, including the combined company’s future financial condition, operating results, strategy and plans; other factors detailed in Monsanto’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) for the fiscal year ended August 31, 2016 and Monsanto’s other filings with the SEC, which are available at and on Monsanto’s website at; and other factors discussed in Bayer’s public reports which are available on the Bayer website at Bayer assumes no obligation to update the information in this communication, except as otherwise required by law. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof.

Additional Information and Where to Find It
This communication relates to the proposed merger transaction involving Monsanto Company (“Monsanto”) and Bayer Aktiengesellschaft (“Bayer”). In connection with the proposed merger, Monsanto and Bayer intend to file relevant materials with the U.S. Securities and Exchange Commission (the “SEC”). Monsanto has filed with the SEC a preliminary proxy statement on Schedule 14A and will file and provide to Monsanto stockholders a definitive proxy statement (the “Proxy Statement”) that will contain important information regarding the proposed merger. This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, and is not a substitute for the Proxy Statement or any other document that Monsanto may file with the SEC or send to its stockholders in connection with the proposed merger. STOCKHOLDERS OF MONSANTO ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED WITH THE SEC, INCLUDING THE DEFINITIVE PROXY STATEMENT, WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain the documents (when available) free of charge at the SEC’s website,, and Monsanto’s website,, and Monsanto stockholders will receive information at an appropriate time on how to obtain transaction-related documents for free from Monsanto. In addition, the documents (when available) may be obtained free of charge by directing a request to Corporate Secretary, Monsanto Company, 800 North Lindbergh Boulevard, St. Louis, Missouri 63167, or by calling (+1) (314) 694-8148.

Participants in Solicitation
Monsanto, Bayer and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the holders of Monsanto common stock in respect of the proposed transaction. Information about the directors and executive officers of Monsanto is set forth in the proxy statement for Monsanto’s 2016 annual meeting of stockholders, which was filed with the SEC on December 10, 2015, and in Monsanto’s Annual Report on Form 10-K for the fiscal year ended August 31, 2016, which was filed with the SEC on October 19, 2016. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the Proxy Statement and other relevant materials to be filed with the SEC in respect of the proposed transaction when they become available.